Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Whitehawk Therapeutics News

Aktie
WKN:  A3CSR9 ISIN:  US00032Q1040 US-Symbol:  WHWK Branche:  Biotechnologie Land:  USA
3,58 €
-0,02 €
-0,56%
11:43:56 Uhr
Depot/Watchlist
Marktkapitalisierung *
56,02 Mio. €
Streubesitz
19,92%
KGV
-3,51
Index-Zuordnung
-

Whitehawk Therapeutics News

16.04.26 - PR Newswire
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series PR Newswire
10.04.26 - PR Newswire
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
Whitehawk Therapeutics Presents Real-​World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026 PR Newswire
17.03.26 - PR Newswire
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
Whitehawk Therapeutics to Highlight its Next-​Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 PR Newswire
12.03.26 - PR Newswire
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights PR Newswire
26.02.26 - PR Newswire
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
18.02.26 - PR Newswire
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference PR Newswire
08.01.26 - PR Newswire
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 PR Newswire
01.12.25 - PR Newswire
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer PR Newswire
26.11.25 - PR Newswire
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference PR Newswire
11.11.25 - PR Newswire
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London PR Newswire
06.11.25 - PR Newswire
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights PR Newswire
24.10.25 - PR Newswire
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC
Whitehawk Therapeutics Presents Real-​World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-​NCI-EORTC PR Newswire
02.09.25 - PR Newswire
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
07.08.25 - PR Newswire
Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights PR Newswire
22.07.25 - PR Newswire
Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference PR Newswire
19.06.25 - PR Newswire
Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series
Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series PR Newswire
28.05.25 - PR Newswire
Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference
Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference PR Newswire
08.05.25 - PR Newswire
Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights
Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights PR Newswire

Newssuche

Videos

newspaper
16.04.26 -0,42%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »